Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.16% Nasdaq Down0.66%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
60.07 Down 1.92(3.10%) 12:27PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 146,873   136,874   136,810   127,928  
Cost of Revenue24,621  28,054  22,567  20,500  
Gross Profit 122,252   108,820   114,243   107,428  
Operating Expenses
Research Development97,312  88,064  85,661  83,743  
Selling General and Administrative71,809  61,841  50,656  51,050  
Non Recurring -   -   -   -  
Others5,441  9,639  (2,022)5,556  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (52,310) (50,724) (20,052) (32,921)
Income from Continuing Operations
Total Other Income/Expenses Net966  (919)527  (9,474)
Earnings Before Interest And Taxes(51,782)(51,790)(19,688)(42,796)
Interest Expense7,593  526  603  1,725  
Income Before Tax(59,375)(52,316)(20,291)(44,521)
Income Tax Expense2,615  704  1,242  (4,711)
Minority Interest -   -   -   -  
Net Income From Continuing Ops(62,428)(53,167)(21,696)(40,211)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (61,990) (53,020) (21,533) (39,810)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (61,990) (53,020) (21,533) (39,810)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.